Dialogue Health Technologies Inc
TSX:CARE
Intrinsic Value
Dialogue Health Technologies, Inc. engages in the development of telemedicine platform. [ Read More ]
The intrinsic value of one CARE stock under the Base Case scenario is 4.76 CAD. Compared to the current market price of 5.14 CAD, Dialogue Health Technologies Inc is Overvalued by 7%.
Valuation Backtest
Dialogue Health Technologies Inc
Run backtest to discover the historical profit from buying and selling CARE stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Dialogue Health Technologies Inc's business.
What risks and challenges
does Dialogue Health Technologies Inc face in the near future?
Summarize the latest earnings report
of Dialogue Health Technologies Inc.
Provide P/E
for Dialogue Health Technologies Inc and its competitors.
Balance Sheet Decomposition
Dialogue Health Technologies Inc
Current Assets | 77.4m |
Cash & Short-Term Investments | 54.2m |
Receivables | 19.6m |
Other Current Assets | 3.6m |
Non-Current Assets | 34.3m |
PP&E | 1.4m |
Intangibles | 30.3m |
Other Non-Current Assets | 2.6m |
Current Liabilities | 19.9m |
Accounts Payable | 16.9m |
Other Current Liabilities | 2.9m |
Non-Current Liabilities | 1m |
Long-Term Debt | 583k |
Other Non-Current Liabilities | 422k |
Earnings Waterfall
Dialogue Health Technologies Inc
Revenue
|
93.5m
CAD
|
Cost of Revenue
|
-41m
CAD
|
Gross Profit
|
52.5m
CAD
|
Operating Expenses
|
-67m
CAD
|
Operating Income
|
-14.6m
CAD
|
Other Expenses
|
-4.3m
CAD
|
Net Income
|
-18.9m
CAD
|
Free Cash Flow Analysis
Dialogue Health Technologies Inc
What is Free Cash Flow?
CARE Profitability Score
Profitability Due Diligence
Dialogue Health Technologies Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Dialogue Health Technologies Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
CARE Solvency Score
Solvency Due Diligence
Dialogue Health Technologies Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
Dialogue Health Technologies Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CARE Price Targets Summary
Dialogue Health Technologies Inc
According to Wall Street analysts, the average 1-year price target for CARE is 4.93 CAD .
Shareholder Return
CARE Price
Dialogue Health Technologies Inc
Average Annual Return | -49.23% |
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -89% |
Market Capitalization | 345.4m CAD |
Shares Outstanding | 67 445 200 |
Percentage of Shares Shorted | 0.18% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dialogue Health Technologies, Inc. engages in the development of telemedicine platform. The company is headquartered in Montreal, Quebec and currently employs 270 full-time employees. The company went IPO on 2021-03-30. The Company’s integrated proprietary product, technology and service providing on-demand access to care. The Company’s Integrated Health Platform is a one-stop healthcare hub that centralizes all its programs in a single application by providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet. Through the Company’s vertically integrated platform, its members and their dependents have access to a team of multidisciplinary professionals who provide wellness services. The firm also offers its members and their dependents access to an employee assistance program (EAP) as well as an Internet-based cognitive behavioral therapy (iCBT) program and an occupational health and safety (OHS) program for customers in Germany.
Contact
IPO
Employees
Officers
The intrinsic value of one CARE stock under the Base Case scenario is 4.76 CAD.
Compared to the current market price of 5.14 CAD, Dialogue Health Technologies Inc is Overvalued by 7%.